Research analysts at StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a note issued to investors on Wednesday. The brokerage set a “sell” rating on the stock.
Ampio Pharmaceuticals Price Performance
NYSE AMPE opened at $0.00 on Wednesday. The firm has a market capitalization of $2,497.00, a price-to-earnings ratio of 0.00 and a beta of 3.67. Ampio Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $7.47.
About Ampio Pharmaceuticals
Featured Articles
- Five stocks we like better than Ampio Pharmaceuticals
- How to buy stock: A step-by-step guide for beginners
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- How Can Investors Benefit From After-Hours Trading
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- What is the Shanghai Stock Exchange Composite Index?
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.